000 | 00917 a2200241 4500 | ||
---|---|---|---|
005 | 20250518022903.0 | ||
264 | 0 | _c20190828 | |
008 | 201908s 0 0 eng d | ||
022 | _a1742-7843 | ||
024 | 7 |
_a10.1111/bcpt.13200 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBergmann, Troels K | |
245 | 0 | 0 |
_aResponse to Letter to the Editor concerning "Progression-free survival (PFS) in oncology: Caveat emptor!" _h[electronic resource] |
260 |
_bBasic & clinical pharmacology & toxicology _c03 2019 |
||
300 |
_a239 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aProgression-Free Survival |
700 | 1 | _aChristensen, Mette Marie H | |
700 | 1 | _aHaastrup, Maija Bruun | |
700 | 1 | _aDamkier, Per | |
773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 124 _gno. 3 _gp. 239 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcpt.13200 _zAvailable from publisher's website |
999 |
_c29356183 _d29356183 |